ArticleClinical Medicine Insights. Oncology2016

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

Nader I Al-Dewik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.